Zebra Technologies Corporation
$ 226.09
1.78%
13 Apr - close price
- Market Cap 11,121,752,000 USD
- Current Price $ 226.09
- High / Low $ 226.35 / 216.47
- Stock P/E 27.64
- Book Value 72.35
- EPS 8.18
- Next Earning Report f
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.06 %
- ROE 0.12 %
- 52 Week High 352.66
- 52 Week Low 199.05
About
Zebra Technologies Corporation is an American company that manufactures and sells marking, tracking, and computer printing technologies. Its products include thermal barcode label and receipt printers, RFID smart label printers/encoders/fixed & handheld readers/antennas, and card and kiosk printers that are used for barcode labeling, personal identification, and specialty printing, principally in the manufacturing, supply chain, retail, healthcare, and government sectors.
Analyst Target Price
$331.50
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-02-12 | 2025-10-28 | 2025-08-05 | 2025-04-29 | 2025-02-13 | 2024-10-29 | 2024-07-30 | 2024-04-30 | 2024-02-15 | 2023-10-31 | 2023-08-01 | 2023-05-02 |
| Reported EPS | 4.33 | 3.88 | 3.61 | 4.02 | 4 | 3.49 | 3.18 | 2.84 | 1.71 | 0.87 | 3.29 | 3.94 |
| Estimated EPS | 4.33 | 3.37 | 3.33 | 3.6174 | 3.9413 | 3.24 | 2.81 | 2.45 | 1.66 | 0.81 | 3.28 | 3.92 |
| Surprise | 0 | 0.51 | 0.28 | 0.4026 | 0.0587 | 0.25 | 0.37 | 0.39 | 0.05 | 0.06 | 0.01 | 0.02 |
| Surprise Percentage | 0% | 15.1335% | 8.4084% | 11.1295% | 1.4894% | 7.716% | 13.1673% | 15.9184% | 3.012% | 7.4074% | 0.3049% | 0.5102% |
Next Quarterly Earnings
| Apr 2026 | |
|---|---|
| Reported Date | f |
| Fiscal Date Ending | o |
| Estimated EPS | r |
| Currency | m |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: ZBRA
2026-04-14 10:21:30
Robeco Institutional Asset Management B.V. decreased its stake in Equinix, Inc. by 3.4% during the fourth quarter, selling 1,773 shares and holding 50,531 shares valued at $38.72 million. Other institutional investors also adjusted their positions in the company, which reported earnings of $8.91 per share, missing consensus estimates, and increased its quarterly dividend to $5.16. Analysts have a "Moderate Buy" consensus rating for Equinix with an average price target of $1,033.57.
2026-04-13 10:09:40
Iridian Asset Management LLC CT significantly reduced its holdings in Rentokil Initial PLC (NYSE:RTO) by 50.1% in the fourth quarter, selling over 300,000 shares but still retaining a substantial stake. This move contrasts with other institutional investors like Envestnet Asset Management Inc. which increased its position. Despite mixed analyst opinions including recent upgrades and downgrades, Rentokil Initial currently holds a "Moderate Buy" consensus rating with an average price target of $34.50.
2026-04-09 20:39:25
Cohen & Steers reported preliminary assets under management (AUM) of $93.1 billion as of March 31, 2026, a decrease of $5.3 billion from the previous month. This decline was primarily driven by $5.0 billion in market depreciation and $323 million in distributions, partially offset by $42 million in net inflows. The company specializes in real assets and alternative income, with offices globally.
2026-04-09 20:12:47
Zebra Technologies CEO Bill Burns exercised stock appreciation rights (SARs) for 4,364 shares at $205.12 per share, with 184 shares withheld for taxes. Following these transactions, Burns now directly owns 75,972 shares of Class A Common Stock. He also retains SARs for an additional 3,901 shares, which have an exercise price of $244.97 and expire in April 2027.
2026-04-09 20:10:47
Zebra Technologies director Anders Gustafsson exercised stock appreciation rights for 65,635 shares of Class A Common Stock at exercise prices of $51.42 and $205.12 per share on April 7, 2026. Following these transactions, including the withholding of 13,900 shares for tax obligations, Gustafsson directly holds 227,492 shares. He also retains stock appreciation rights for an additional 20,134 underlying shares, set to expire on April 30, 2027.
2026-04-09 18:08:51
Champions Oncology (NASDAQ:CSBR) will present eight poster studies at the AACR Annual Meeting in San Diego from April 17-22, 2026. The presentations will cover various types of cancer and innovative therapeutic approaches, emphasizing the company's commitment to using patient-derived models and integrated data to enhance drug development and predict treatment responses. This initiative aims to reduce translational risk and inform development decisions earlier in the oncology pipeline.
